# PPI Therapy Impact on GERD After Sleeve Gastrectomy

> **NCT04400136** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 45 (estimated)

## Conditions studied

- Gastro Esophageal Reflux
- Barrett Esophagus
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Lansoprazole oral tablets 30 mg

## Key facts

- **NCT ID:** NCT04400136
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2020-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400136, "PPI Therapy Impact on GERD After Sleeve Gastrectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04400136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*